摘要
目的:观察茵栀黄颗粒联合思密达治疗新生儿母乳性黄疸的临床疗效。方法:采用随机数字表法将100例新生儿母乳性黄疸患儿分为治疗组与对照组各50例。2组患儿均给予常规母乳喂养,同时给予蓝光照射治疗和抚触治疗,2次/d。治疗组在此基础上加用茵栀黄颗粒0.1包/次,3次/d,温水冲服;思密达1.0 g,以10%葡萄糖注射液15 mL调匀后喂服,3次/d。2组均以治疗7天为1个疗程,直至血清总胆红素含量下降至119.7μmol/L以下停止上述治疗。结果:痊愈率治疗组为72.00%,对照组为58.00%;总有效率治疗组为98.00%,对照组为84.00%。2组治愈率、总有效率相比差异有统计学意义(P<0.05)。治疗后2组血清总胆红素值与治疗前相比差异有统计学意义(P<0.05);治疗后血清总胆红素值、胆红素日均下降值、治愈时间、住院时间等一般资料2组相比差异有统计学意义(P<0.05)。结论:茵栀黄颗粒联合思密达治疗新生儿母乳性黄疸临床疗效显著,可明显降低血清总胆红素水平,缩短住院时间。
Objective：To observe clinical effects of YinZhiHuang granules and smecta in treating neonatal breast milk jaundice.Method：One hundred cases were divided into the treatment group and the control group equally with random number table.Both groups received breast milk,also blue light irradiation and caress,twice each day.The treatment group took YinZhiHuang granules,0.1 package once,three times each day,administered after mixing the medicine with water;smecta 1.0 g,taking after mixing it with 15 mL of 10% glucose injection,three times each day.One course of treatment was seven days,the therapy couldn’t stop until the content of serum total bilirubin decreased to 119.7 μmol/L.Result：The cure rates of the treatment group and the control group were 72.00% and 58.00%;total effective rates of both groups were 98.00% and 84.00%.Comparisons of both groups suggested significant difference in the cure rate and total effective rate（P0.05）.The index of total bilirubin showed significant difference before treating compared with that after treating（P0.05）;comparisons of both groups demonstrated significant difference in average decline of total bilirubin and bilirubin,healing time,hospitalization time and others（P0.05）.Conclusion：YinZhiHuang granules and smecta,effective in treating neonatal breast milk jaundice,can obviously decrease the level of serum total bilirubin and shorten the hospitalization days.
出处
《西部中医药》
2013年第1期95-96,共2页
Western Journal of Traditional Chinese Medicine
关键词
黄疸
母乳性
新生儿
妈咪爱
茵栀黄
jaundice
breast milk
neonatal
medilac-Vita
YinZhiHuang granules
